Ponzo Marisa Grace, Miliszewski Monica, Kirchhof Mark G, Keown Paul A, Dutz Jan P
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.
Division of Dermatology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
J Cutan Med Surg. 2019 Nov/Dec;23(6):595-601. doi: 10.1177/1203475419867599. Epub 2019 Aug 5.
East Asians exposed to the urate-lowering drug allopurinol have a predilection for severe cutaneous drug reactions such as drug-induced hypersensitivity syndrome or drug reaction with eosinophilia and systemic symptoms (DRESS) and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). Screening is recommended in patients of East Asian descent for the presence of prior to allopurinol initiation to avoid these complications. Utilization rates of the predictive screening test within the Greater Vancouver area, which has a population composed of 40.1% people of East Asian descent, are unknown.
We identified cases of DRESS or SJS/TEN due to allopurinol using the Vancouver General Hospital dermatology consult service database. We next compared the frequency in which the screening test was ordered since 2012 to the estimated frequency of new prescriptions for allopurinol prescribed for the management of gout among the East Asians.
We report 5 cases of East Asian patients exposed to allopurinol for management of gout between 2012 and 2016, who developed DRESS (4 patients) or SJS/TEN (1 patient). All were of genotype, representing preventable cases. The test was ordered 6 times in 2012, whereas the estimated number of new cases of allopurinol-prescribed gout among patients of East Asian descent during that time period was 13. For 2012, testing was ordered for only 46% of at-risk patients.
We continue to observe cases of severe cutaneous drug reactions among high-risk individuals due to allopurinol exposure. The screening test for allopurinol hypersensitivity is underutilized in our geographic area.
使用降尿酸药物别嘌醇的东亚人易发生严重的皮肤药物反应,如药物性超敏反应综合征或伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)以及史蒂文斯 - 约翰逊综合征/中毒性表皮坏死松解症(SJS/TEN)。建议在开始使用别嘌醇之前对东亚血统的患者进行筛查,以避免这些并发症。大温哥华地区的人口中40.1%为东亚血统,该地区预测性筛查试验的使用率尚不清楚。
我们使用温哥华总医院皮肤科会诊服务数据库确定了因别嘌醇导致的DRESS或SJS/TEN病例。接下来,我们将自2012年以来进行筛查试验的频率与东亚人中为治疗痛风而开具的别嘌醇新处方估计频率进行了比较。
我们报告了2012年至2016年间5例接受别嘌醇治疗痛风的东亚患者,他们发生了DRESS(4例患者)或SJS/TEN(1例患者)。所有患者均为[具体基因型],代表可预防的病例。2012年进行了6次筛查试验,而在此期间东亚血统患者中别嘌醇处方痛风的新病例估计数为13例([此处原文缺失具体数据,推测是计算比例的分母数据缺失])。2012年,仅对46%的高危患者进行了检测。
我们仍在观察因接触别嘌醇而在高危个体中发生严重皮肤药物反应的病例。我们所在地区别嘌醇超敏反应的筛查试验未得到充分利用。